What could SUD be worth?, page-3

Hey Nununki
The biggest concern I have for SUD is the short term cash position of the company. IE next 18 months and making sure there is not a need to go back to the market for funding. Medium /long term I think it's potentially a great investment if we get through this short term period. There will be royalties commencing for the two done deals and hopefully 3 to 5 more been completed by then and awaiting territory registrations. This being the case the cash position will be sound with the option conversion of $9 MIL up their sleeve because the share price will run on future cash flow expectations.

The Big ticket for mine is midazolam (005 product) and or potentially anagrelide . These can be your multi $100 MIL pay day products. Throw in there 003 which I don't necessarily hold much hope for nor Artimist.

In short give us some certainly about the short term by way of a few more deals (1. to bump up the SP for oppie conversion and 2. for the upfront cash payment component) and I'm happy to bank on a $150 MIL MKT cap in the next 6-9 months. Could even happen much much sooner.

If we get the deals in the coming weeks and months it can very quickly become a no brainer. The share price is a key ingredient to future success. We need those oppies converted whilst we await the serious royalty and big global deal days to start kicking.